| Back to Search | |
| Study ID |
106855 |
| Clinical Study ID |
HZA106855 |
| Study Title | A dose-ranging study of fluticasone furoate (FF) inhalation powder in children aged 5-11 years with asthma |
| Patient Level Data | Study Listed on ClinicalStudyDataRequest.com |
| Clinicaltrials.gov Identifier | NCT01563029 |
| Sponsor | GlaxoSmithKline |
| Collaborators | N/A |
| Phase | Phase 2 |
| Study Recruitment Status | Completed |
| Generic Name | fluticasone furoate |
| Trade Name | Allermist,Avamys,Veramyst; Veramyst,Avamys,Allermist |
| Study Indication | Asthma |
| First Received | Last Updated | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 08, 2012 | Apr 25, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Click to view inclusion/exclusion criteria| Document Title | First Received | Last Updated |
|---|---|---|
| Mar 13, 2015 | Mar 13, 2015 |
| Document Title | First Received | Last Updated |
|---|---|---|
| Nov 14, 2016 | Nov 14, 2016 |
|
||||||
| Location Name | Status | ||||||
|---|---|---|---|---|---|---|---|
|
|||||||
| Bulgaria | |||||||
| GSK Investigational Site Bulgaria, Plovdiv, 4003 Nina Markova, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Bulgaria, Plovdiv, 4002 Miroslava Bosheva, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Bulgaria, Ruse, 7000 Svetoslav Dachev, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Bulgaria, Sofia, None Rada Markova, Principal Investigator |
COMPLETED | ||||||
| Georgia | |||||||
| GSK Investigational Site Georgia, Tbilisi, 0159 Liana Zhorzholiani, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Georgia, Tbilisi, 0186 Alexandre Telia, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Georgia, Tbilisi, 0159 Maia Gotua, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Georgia, Tbilisi, 0160 Nikoloz Djorbenadze, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Georgia, Tbilisi, 0119 Tinatin Gigauri, Principal Investigator |
COMPLETED | ||||||
| Germany | |||||||
| GSK Investigational Site Germany, Baden-Wuerttemberg, Mannheim, 68163 Marcus Dahlheim, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Germany, Bayern, Berchtesgaden, 83471 Michael Horn, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Germany, Bayern, Rosenheim, 83026 Otto Laub, Principal Investigator |
TERMINATED | ||||||
| GSK Investigational Site Germany, Berlin, Berlin, 10785 Karl Paul-Buck, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Germany, Hamburg, Hamburg, 22415 Friedrich Kaiser, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Germany, Hessen, Frankfurt am Main, 60596 Stefan Zielen, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Germany, Hessen, Neu isenburg, 63263 Frank Freytag, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Germany, Hessen, Niedernhausen, 65527 Hartmut Scheele, Principal Investigator |
TERMINATED | ||||||
| GSK Investigational Site Germany, Niedersachsen, Goettingen, 37073 Matthias Feindt, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Germany, Niedersachsen, Wolfenbuettel, 38302 Isabel Ferger, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Germany, Nordrhein-Westfalen, Bochum, 44791 Eckard Hamelmann, Principal Investigator |
TERMINATED | ||||||
| GSK Investigational Site Germany, Nordrhein-Westfalen, Hamm, 59063 Wolfgang Kamin, Principal Investigator |
TERMINATED | ||||||
| GSK Investigational Site Germany, Nordrhein-Westfalen, Kleve-Materborn, 47533 Peter Soemantri, Principal Investigator |
TERMINATED | ||||||
| GSK Investigational Site Germany, Nordrhein-Westfalen, Telgte, 48291 Christopher Kolorz, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Germany, Sachsen, Dresden, 01307 Christian Vogelberg, Principal Investigator |
TERMINATED | ||||||
| GSK Investigational Site Germany, Schleswig-Holstein, Geesthacht, 21502 Wolfgang Zachgo, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Germany, Thueringen, Neuhaus am Rennweg, 98724 Ute Macholdt, Principal Investigator |
TERMINATED | ||||||
| Japan | |||||||
| GSK Investigational Site Japan, Chiba, 260-0001 Toshikazu Tsubaki, Principal Investigator |
TERMINATED | ||||||
| GSK Investigational Site Japan, Fukuoka, 811-1394 Hiroshi Odajima, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Japan, Hiroshima, 720-8520 Masanori Ikeda, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Japan, Hokkaido, 006-0831 Toru Watanabe, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Japan, Hokkaido, 064-0821 Atsushi Tame, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Japan, Hyogo, 653-0021 Akihiko Hirase, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Japan, Kagawa, 762-0031 Kiyotaka Tanimoto, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Japan, Mie, 514-0125 Takao Fujisawa, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Japan, Osaka, 583-8588 Satoru Doi, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Japan, Tokyo, 158-0097 Toshikazu Nagakura, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Japan, Tokyo, 157-0066 Akiyoshi Sasamoto, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Japan, Tokyo, 154-0017 Masahiko Tsuda, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Japan, Wakayama, 646-8558 Chizu Habukawa, Principal Investigator |
COMPLETED | ||||||
| Latvia | |||||||
| GSK Investigational Site Latvia, Daugavpils, LV5403 Aina Maskalane, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Latvia, Rezekne, LV-4601 Viktorija Vevere, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Latvia, Riga, LV1011 Renate Snipe, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Latvia, Riga, LV 1004 Ieva Cirule, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Latvia, Riga, LV 1003 Marite Poga, Principal Investigator |
COMPLETED | ||||||
| Mexico | |||||||
| GSK Investigational Site Mexico, Ciudad de México, 06720 Blanca Del Rio-Navarro, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Mexico, Mexico, 04530 Socorro Orozco-Martínez, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Mexico, Mexico City, 07760 Norma Martínez-Jiménez, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Mexico, Jalisco, Guadalajara, 44100 Dante Daniel Hernández-Colín, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Mexico, Jalisco, Zapopan, 45040 Alfredo Gazca-Aguilar, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Mexico, Michoacán, Morelia, 58070 Juan Manuel Zaragoza-Benitez, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Mexico, Tabasco, Villahermosa, 86100 Ruth Cerino-Javier, Principal Investigator |
COMPLETED | ||||||
| Peru | |||||||
| GSK Investigational Site Peru, Lima, Lima, Lima 29 Jorge De Los Rios Senmache, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Peru, Lima, Lima, Lima 11 Rolando A Estrella Viladegut, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Peru, Lima, Lima, Lima 27 Miguel Tsukayama, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Peru, Lima, Lima 18, None Carlos Minauro, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Peru, Lima, Lima 27, Lima 27 Cesar Villarán, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Peru, Lima, San Borja, Lima 41 Jose Torres, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Peru, Lima, San Miguel, Lima 32 Marco Cámere, Principal Investigator |
COMPLETED | ||||||
| Philippines | |||||||
| GSK Investigational Site Philippines, Manila, 1003 Cesar M Ong, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Philippines, Manila, 1000 Madeleine W Sumpaico, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Philippines, Quezon City, 1113 Linda Lim-Varona, Principal Investigator |
TERMINATED | ||||||
| Poland | |||||||
| GSK Investigational Site Poland, Bialystok, 15-183 Teresa Piotrowska, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Poland, Bialystok, 15-430 Anna Ploszczuk, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Poland, Bydgoszcz, 85-046 Renata Bijata-Bronisz, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Poland, Debica, 39-200 Jerzy Brzostek, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Poland, Kielce, 25-017 Anna Latos, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Poland, Lodz, 93-513 Agnieszka Brzozowska, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Poland, Lublin, 20-093 Andrzej Emeryk, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Poland, Lublin, 20-552 Izabella Krupa-Borek, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Poland, Lublin, 20-089 Zofia Bartnik, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Poland, Poznan, 60-693 Ewa Springer, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Poland, Tarnow, 33-100 Bernadetta Majorek-Olechowska, Principal Investigator |
COMPLETED | ||||||
| Puerto Rico | |||||||
| GSK Investigational Site Puerto Rico, Puerto Rico, Hato Rey, 00917 Jose R Rodriguez-Santana, Principal Investigator |
COMPLETED | ||||||
| Russian Federation | |||||||
| GSK Investigational Site Russian Federation, Blagoveshchensk, 675000 Juliy M Perelman, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Russian Federation, Moscow, 119991 Leila S Namazova-Baranova, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Russian Federation, Murmansk, 183031 Vera Y Rodnikova, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Russian Federation, Novokuznetsk, 654063 Tatyana G Golosova, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Russian Federation, Novosibirsk, 630091 Elena G Kondyrina, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Russian Federation, St. Petersburg, 194356 Natalya Soroka, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Russian Federation, St. Petersburg, 194356 Svetlana G Lazareva, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Russian Federation, Voronezh, 394036 Elena Chertok, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Russian Federation, Yaroslavl, 150003 |
COMPLETED | ||||||
| South Africa | |||||||
| GSK Investigational Site South Africa, CapeTown, 7764 Rehana Loghdey, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site South Africa, Middelburg, 1501 Ayesha Bassa, Principal Investigator |
TERMINATED | ||||||
| GSK Investigational Site South Africa, Western Province, Panorama, 7500 Jan Vermeulen, Principal Investigator |
COMPLETED | ||||||
| Sweden | |||||||
| GSK Investigational Site Sweden, GÖTEBORG, SE-416 85 Bill Hesselmar, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Sweden, KUNGSBACKA, SE-434 30 Inger Winnergård, Principal Investigator |
TERMINATED | ||||||
| GSK Investigational Site Sweden, ÖREBRO, SE-701 85 Östen Jonsson, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Sweden, STOCKHOLM, SE171 76 Gunilla Hedlin, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Sweden, STOCKHOLM, SE-118 83 Björn Lundberg, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Sweden, UPPSALA, SE-752 26 Fredrik Cederblad, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Sweden, VISBY, SE-621 84 Bo Klintberg, Principal Investigator |
COMPLETED | ||||||
| Ukraine | |||||||
| GSK Investigational Site Ukraine, Chernivtsi, 58001 Yuriy Nechitailo, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Ukraine, Ivano-Frankivsk, 76018 Andriy Volosyanko, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Ukraine, Kharkiv, 61093 Ganna S Senatorova, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Ukraine, Kherson, 73000 Liudmyla Bogatchuk, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Ukraine, Kyiv, 04050 Volodymyr F Lapshyn, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Ukraine, Kyiv, 03680 Viktoriia P Kostromina, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Ukraine, Luhansk, 91000 Boris Bezkaravaynyi, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Ukraine, Simferopol, 95034 Svitlana V Trishina, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Ukraine, Vinnytsia, 21021 Nataliya Sinchuk, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Ukraine, Yevpatoriia, 97408 Mykola Kaladze, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Ukraine, Zaporizhia, 69063 Tetyana I Okul, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site Ukraine, Zaporizhia, 69076 Svetlana Nedelskaya, Principal Investigator |
COMPLETED | ||||||
| United States | |||||||
| Arkansas | |||||||
| GSK Investigational Site United States, Arkansas, Little Rock, 72205 Karl V Sitz, Principal Investigator |
COMPLETED | ||||||
| California | |||||||
| GSK Investigational Site United States, California, Costa Mesa, 92626 Suzanne Kim, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site United States, California, Huntington Beach, 92647 Paul Y Qaqundah, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site United States, California, Long Beach, 90808 Steven M Meltzer, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site United States, California, Newport Beach, 92663 Ryan M Klein, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site United States, California, Orange, 92868 Mark Ellis, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site United States, California, Rolling Hills Estates, 90274 Lawrence D Sher, Principal Investigator |
COMPLETED | ||||||
| Florida | |||||||
| GSK Investigational Site United States, Florida, Aventura, 33180 Jaime Landman, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site United States, Florida, Cocoa, 32927 Rameshwar Mathur, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site United States, Florida, Miami, 33173 Michael P Pacin, Principal Investigator |
COMPLETED | ||||||
| Georgia | |||||||
| GSK Investigational Site United States, Georgia, Columbus, 31904 Robert R Chrzanowski, Principal Investigator |
TERMINATED | ||||||
| Idaho | |||||||
| GSK Investigational Site United States, Idaho, Eagle, 83616 Stephen B Fritz, Principal Investigator |
COMPLETED | ||||||
| Illinois | |||||||
| GSK Investigational Site United States, Illinois, Normal, 61761 Nicholas A Nayak, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site United States, Illinois, Shiloh, 62269 Patrick H Win, Principal Investigator |
COMPLETED | ||||||
| Kansas | |||||||
| GSK Investigational Site United States, Kansas, Lenexa, 66215 Khaled R Girgis, Principal Investigator |
COMPLETED | ||||||
| Kentucky | |||||||
| GSK Investigational Site United States, Kentucky, Owensboro, 42301 Lee S Clore, Principal Investigator |
COMPLETED | ||||||
| Michigan | |||||||
| GSK Investigational Site United States, Michigan, Stevensville, 49127 Richard L Hines, Principal Investigator |
TERMINATED | ||||||
| Minnesota | |||||||
| GSK Investigational Site United States, Minnesota, Plymouth, 55441 Allan Stillerman, Principal Investigator |
COMPLETED | ||||||
| Missouri | |||||||
| GSK Investigational Site United States, Missouri, Columbia, 65203 Mark L Vandewalker, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site United States, Missouri, Rolla, 65401 Ita Tripathy, Principal Investigator |
COMPLETED | ||||||
| New York | |||||||
| GSK Investigational Site United States, New York, Corning, 14830 Christopher A Smith, Principal Investigator |
COMPLETED | ||||||
| North Carolina | |||||||
| GSK Investigational Site United States, North Carolina, Raleigh, 27607 Karen D Dunn, Principal Investigator |
COMPLETED | ||||||
| Ohio | |||||||
| GSK Investigational Site United States, Ohio, Canton, 44718 John T Given, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site United States, Ohio, Cincinnati, 45231 David I Bernstein, Principal Investigator |
COMPLETED | ||||||
| Oklahoma | |||||||
| GSK Investigational Site United States, Oklahoma, Oklahoma City, 73112 Santiago Reyes, Principal Investigator |
COMPLETED | ||||||
| Oregon | |||||||
| GSK Investigational Site United States, Oregon, Medford, 97504 Edward M Kerwin, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site United States, Oregon, Portland, 97202 Anthony Montanaro, Principal Investigator |
COMPLETED | ||||||
| Pennsylvania | |||||||
| GSK Investigational Site United States, Pennsylvania, Pittsburgh, 15241 James N DeAngelo, Principal Investigator |
COMPLETED | ||||||
| South Carolina | |||||||
| GSK Investigational Site United States, South Carolina, Charleston, 29407 Ned T Rupp, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site United States, South Carolina, Orangeburg, 29118 Richard E Sterling, Principal Investigator |
COMPLETED | ||||||
| Texas | |||||||
| GSK Investigational Site United States, Texas, Austin, 78750 Glen Journeay, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site United States, Texas, Dallas, 75230 Richard L Wasserman, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site United States, Texas, El Paso, 79925 Rogelio Menendez, Principal Investigator |
TERMINATED | ||||||
| GSK Investigational Site United States, Texas, San Antonio, 78258 Kelly J Smith, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site United States, Texas, San Antonio, 78229 Joseph Diaz, Principal Investigator |
COMPLETED | ||||||
| GSK Investigational Site United States, Texas, Waco, 76712 Niran J Amar, Principal Investigator |
COMPLETED | ||||||
| Vermont | |||||||
| GSK Investigational Site United States, Vermont, South Burlington, 05403 Edward F Kent, Principal Investigator |
COMPLETED | ||||||
Quick Search
Useful Links
For more information on this register please email GSKClinicalSupportHD@gsk.com
GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.
IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).
This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.
EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.